Interaction between cell and extracellular matrix in heart disease: multiple roles of tenascin-C in tissue remodeling.

The heart remodels myocardial tissue in physiological and pathological response. The cell-extracellular matrix (ECM) interaction provides not only structural and mechanical support but also important biological signaling during tissue remodeling. Among various ECM molecules, tenascin-C (TNC) is well known as a regulator of multiple cellular functions during embryogenesis, wound healing or cancer progression. In the heart, TNC appears in several important steps of embryonic development such as the initial differentiation of cardiomyocytes or coronary vasculo/angiogenesis, but it is not detected in a normal adult myocardium. However, TNC is found to re-express after myocardial injury and may regulate cellular behavior during tissue remodeling by modulating the attachment of cardiomyocytes to connective tissue, by enhancing migration and differentiation of myofibroblasts, and by inducing matrix metallo-proteinases. TNC also interacts with other ECM molecules and may modulate progression of fibrosis. Furthermore, transient and site specific expression of TNC closely associated with myocardial injury and inflammation suggests not only its key roles during tissue remodeling but also that TNC can be a marker for myocardial disease activity.

[1]  G. Gabbiani,et al.  The myofibroblast in wound healing and fibrocontractive diseases , 2003, The Journal of pathology.

[2]  Matthias Chiquet,et al.  Tenascins: regulation and putative functions during pathological stress , 2003, The Journal of pathology.

[3]  E. Creemers,et al.  The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis , 2003, The Journal of pathology.

[4]  T. Sakakura,et al.  Involvement of large tenascin-C splice variants in breast cancer progression. , 2003, The American journal of pathology.

[5]  Ken-ichi Matsumoto,et al.  The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse. , 2003, Differentiation; research in biological diversity.

[6]  T. Sakakura,et al.  Tenascin‐C upregulates matrix metalloproteinase‐9 in breast cancer cells: Direct and synergistic effects with transforming growth factor β1 , 2003, International journal of cancer.

[7]  Matthias Chiquet,et al.  How do fibroblasts translate mechanical signals into changes in extracellular matrix production? , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[8]  E. Schiffrin,et al.  Vascular inflammation: a role in vascular disease in hypertension? , 2003, Current opinion in nephrology and hypertension.

[9]  M. Järvinen,et al.  Mechanical loading regulates the expression of tenascin-C in the myotendinous junction and tendon but does not induce de novo synthesis in the skeletal muscle , 2003, Journal of Cell Science.

[10]  Ryozo Nagai,et al.  Gene Expression in Fibroblasts and Fibrosis: Involvement in Cardiac Hypertrophy , 2002, Circulation research.

[11]  Douglas L Mann,et al.  Inflammatory mediators and the failing heart: past, present, and the foreseeable future. , 2002, Circulation research.

[12]  A. McCulloch,et al.  Dance Band on the Titanic Biomechanical Signaling in Cardiac Hypertrophy , 2002 .

[13]  P. Bornstein,et al.  Matricellular proteins: extracellular modulators of cell function. , 2002, Current opinion in cell biology.

[14]  E. Greene,et al.  TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells. , 2002, American journal of physiology. Renal physiology.

[15]  J. Schwarzbauer,et al.  Tenascin-C modulates matrix contraction via focal adhesion kinase- and Rho-mediated signaling pathways. , 2002, Molecular biology of the cell.

[16]  S. Tanada,et al.  Detection of Experimental Autoimmune Myocarditis in Rats by 111In Monoclonal Antibody Specific for Tenascin-C , 2002, Circulation.

[17]  M. Hiroe,et al.  Tenascin‐C is a useful marker for disease activity in myocarditis , 2002, The Journal of pathology.

[18]  M. Entman,et al.  Active interstitial remodeling: an important process in the hibernating human myocardium. , 2002, Journal of the American College of Cardiology.

[19]  Jeffrey C. Allen,et al.  Tenascin-C promotes microvascular cell migration and phosphorylation of focal adhesion kinase. , 2002, Cancer research.

[20]  R. Visse,et al.  Matrix Metalloproteinases Regulation and Dysregulation in the Failing Heart , 2002 .

[21]  C. Stier,et al.  Aldosterone as a Mediator in Cardiovascular Injury , 2002, Cardiology in review.

[22]  R. Ross,et al.  Integrins and the myocardium. , 2001, Genetic engineering.

[23]  H. Erickson,et al.  Focal Adhesion Integrity Is Downregulated by the Alternatively Spliced Domain ofHumanTenascin , 2002 .

[24]  M. Entman,et al.  The inflammatory response in myocardial infarction. , 2002, Cardiovascular research.

[25]  J. Moyano,et al.  Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. , 2001, Cancer research.

[26]  R. Strausberg,et al.  Transcriptional response to hypoxia in human tumors. , 2001, Journal of the National Cancer Institute.

[27]  K. Shimada,et al.  Quantitative analysis of tenascin in chordae tendineae of human left ventricular papillary muscle with aging. , 2001, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[28]  R. Levy,et al.  Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis. , 2001, The American journal of pathology.

[29]  M. Hiroe,et al.  Tenascin-C Modulates Adhesion of Cardiomyocytes to Extracellular Matrix during Tissue Remodeling after Myocardial Infarction , 2001, Laboratory Investigation.

[30]  J. Murphy-Ullrich The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? , 2001, The Journal of clinical investigation.

[31]  Hayden. Huang,et al.  Regulation of Cardiomyocyte Mechanotransduction by the Cardiac Cycle , 2001, Circulation.

[32]  T. Nakano,et al.  Serial extracellular matrix changes in neointimal lesions of human coronary artery after percutaneous transluminal coronary angioplasty: clinical significance of early tenascin-C expression , 2001, Virchows Archiv.

[33]  T. Sakakura,et al.  Expression of Tenascin-C in Stromal Cells of the Murine Uterus During Early Pregnancy: Induction by Interleukin-1α, Prostaglandin E2, and Prostaglandin F2α , 2000 .

[34]  P. Jones,et al.  Tenascin-C in development and disease: gene regulation and cell function. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[35]  P. Kannus,et al.  Tenascin‐C in the pathobiology and healing process of musculoskeletal tissue injury , 2000, Scandinavian journal of medicine & science in sports.

[36]  R. Chiquet‐Ehrismann,et al.  Adhesion modulation by antiadhesive molecules of the extracellular matrix. , 2000, Experimental cell research.

[37]  E. Braunwald,et al.  Congestive Heart Failure: Fifty Years of Progress , 2000, Circulation.

[38]  J. Schwarzbauer,et al.  Tenascin-C Suppresses Rho Activation , 2000, The Journal of cell biology.

[39]  B. Lorell,et al.  Left ventricular hypertrophy: pathogenesis, detection, and prognosis. , 2000, Circulation.

[40]  N. Sharpe,et al.  Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. , 2000, Circulation.

[41]  P. Jones,et al.  The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling , 2000, Developmental dynamics : an official publication of the American Association of Anatomists.

[42]  J. Cohn,et al.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. , 2000, Journal of the American College of Cardiology.

[43]  K. Imanaka-Yoshida,et al.  The transmission of contractility through cell adhesion. , 2000, Progress in molecular and subcellular biology.

[44]  T. Sakakura,et al.  Expression of tenascin-C in stromal cells of the murine uterus during early pregnancy: induction by interleukin-1 alpha, prostaglandin E(2), and prostaglandin F(2 alpha). , 2000, Biology of reproduction.

[45]  K. Fujimoto,et al.  Remodeling of cell-cell and cell-extracellular matrix interactions at the border zone of rat myocardial infarcts. , 1999, Circulation research.

[46]  R. Tucker,et al.  The tenascin-C knockout revisited. , 1999, Journal of cell science.

[47]  T. Sakakura,et al.  Involvement of tenascin-C in proliferation and migration of laryngeal carcinoma cells , 1999, Virchows Archiv.

[48]  M. Chiquet,et al.  Regulation of extracellular matrix gene expression by mechanical stress. , 1999, Matrix biology : journal of the International Society for Matrix Biology.

[49]  C. Streuli,et al.  Extracellular matrix remodelling and cellular differentiation. , 1999, Current opinion in cell biology.

[50]  G. Gabbiani,et al.  Mechanisms of myofibroblast activity and phenotypic modulation. , 1999, Experimental cell research.

[51]  Richard T. Lee,et al.  Induction of Tenascin-C in Cardiac Myocytes by Mechanical Deformation , 1999, The Journal of Biological Chemistry.

[52]  A B West,et al.  Myofibroblasts: paracrine cells important in health and disease. , 2000, Transactions of the American Clinical and Climatological Association.

[53]  P. Jones,et al.  Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis. , 1999, Circulation research.

[54]  T. Sakakura,et al.  Vinculin, Talin, Integrin alpha6beta1 and laminin can serve as components of attachment complex mediating contraction force transmission from cardiomyocytes to extracellular matrix. , 1999, Cell motility and the cytoskeleton.

[55]  J. A. Greenwood,et al.  Signaling of de‐adhesion in cellular regulation and motility , 1998, Microscopy research and technique.

[56]  D. Mann,et al.  Activation of matrix metalloproteinases in the failing human heart: breaking the tie that binds. , 1998, Circulation.

[57]  R. Pfundt,et al.  Tenascin-C expression in human epidermal keratinocytes is regulated by inflammatory cytokines and a stress response pathway. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[58]  G. Gabbiani,et al.  Evolution and clinical implications of the myofibroblast concept. , 1998, Cardiovascular research.

[59]  Andres F. Oberhauser,et al.  The molecular elasticity of the extracellular matrix protein tenascin , 1998, Nature.

[60]  P. Jones,et al.  Regulation of Tenascin-C, a Vascular Smooth Muscle Cell Survival Factor that Interacts with the αvβ3 Integrin to Promote Epidermal Growth Factor Receptor Phosphorylation and Growth , 1997, The Journal of cell biology.

[61]  T. Sakakura,et al.  Expression of fibronectin and tenascin‐C mRNA by myofibroblasts, vascular cells and epithelial cells in human colon adenomas and carcinomas , 1997, International journal of cancer.

[62]  T. Sakakura,et al.  Co‐expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast , 1997, The Journal of pathology.

[63]  T. Sakakura,et al.  Analysis of tenascin mRNA expression in the murine mammary gland from embryogenesis to carcinogenesis: an in situ hybridization study. , 1997, The International journal of developmental biology.

[64]  T. Schulthess,et al.  Concerted action of tenascin-C domains in cell adhesion, anti-adhesion and promotion of neurite outgrowth. , 1997, Journal of cell science.

[65]  H. Erickson,et al.  Glycosaminoglycans modulate fibronectin matrix assembly and are essential for matrix incorporation of tenascin-C. , 1997, Journal of cell science.

[66]  M. Mattson,et al.  Oxidative stress mediates monocrotaline-induced alterations in tenascin expression in pulmonary artery endothelial cells. , 1997, The international journal of biochemistry & cell biology.

[67]  S. Hoffman,et al.  IL-4 upregulates tenascin synthesis in scleroderma and healthy skin fibroblasts. , 1996, The Journal of investigative dermatology.

[68]  J. Arends,et al.  TENASCIN AND FIBRONECTIN EXPRESSION IN HEALING HUMAN MYOCARDIAL SCARS , 1996, The Journal of pathology.

[69]  S. Werner,et al.  Skin wounds and severed nerves heal normally in mice lacking tenascin-C. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[70]  H. Erickson,et al.  Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. , 1996, Molecular biology of the cell.

[71]  T. Mikawa,et al.  Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. , 1996, Developmental biology.

[72]  S. Kusachi,et al.  Tenascin expression in endomyocardial biopsy specimens in patients with dilated cardiomyopathy: distribution along margin of fibrotic lesions. , 1996, Heart.

[73]  J. Sanger,et al.  Living adult rat cardiomyocytes in culture: evidence for dissociation of costameric distribution of vinculin from costameric distributions of attachments. , 1996, Cell motility and the cytoskeleton.

[74]  H. Erickson,et al.  Binding of Tenascin-C to Soluble Fibronectin and Matrix Fibrils * , 1995, The Journal of Biological Chemistry.

[75]  S. Aizawa,et al.  Tenascin‐C induction by the diffusible factor epidermal growth factor in stromal‐epithelial interactions , 1995, Journal of cellular physiology.

[76]  P. Bornstein,et al.  Diversity of Function Is Inherent in Matricellular Proteins: an Appraisal of Thrombospondin I , 1995 .

[77]  V. Kinnula,et al.  Modulation of fibronectin and tenascin production in human bronchial epithelial cells by inflammatory cytokines in vitro. , 1995, American journal of respiratory cell and molecular biology.

[78]  J. Spring,et al.  Tenascin-C expression by fibroblasts is elevated in stressed collagen gels , 1994, The Journal of cell biology.

[79]  D. Friedlander,et al.  Interactions of the chondroitin sulfate proteoglycan phosphacan, the extracellular domain of a receptor-type protein tyrosine phosphatase, with neurons, glia, and neural cell adhesion molecules , 1994, The Journal of cell biology.

[80]  H. Erickson,et al.  Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C , 1994, The Journal of cell biology.

[81]  J. Schlessinger,et al.  Receptor tyrosine phosphatase beta is expressed in the form of proteoglycan and binds to the extracellular matrix protein tenascin. , 1994, The Journal of biological chemistry.

[82]  R. U. Margolis,et al.  Interactions with tenascin and differential effects on cell adhesion of neurocan and phosphacan, two major chondroitin sulfate proteoglycans of nervous tissue. , 1994, The Journal of biological chemistry.

[83]  Z. Werb,et al.  The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. , 1994, Molecular biology of the cell.

[84]  H. Erickson,et al.  Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways. , 1994, Journal of cell science.

[85]  L. Vaughan,et al.  Tenascin-contactin/F11 interactions: a clue for a developmental role? , 1994, Perspectives on developmental neurobiology.

[86]  A. G. Gittenberger-de Groot,et al.  Development of the cardiac coronary vascular endothelium, studied with antiendothelial antibodies, in chicken-quail chimeras. , 1993, Circulation research.

[87]  G. Lamas,et al.  Ventricular remodeling after myocardial infarction. , 1993, Advances in experimental medicine and biology.

[88]  E. Wisse,et al.  Tenascin expression in human chronic liver disease and in hepatocellular carcinoma. , 2008, Liver.

[89]  J. Forrester,et al.  Angiotensin II regulates tenascin gene expression in vascular smooth muscle cells. , 1992, The Journal of biological chemistry.

[90]  T. Mikawa,et al.  Clonal analysis of cardiac morphogenesis in the chicken embryo using a replication‐defective retrovirus. III: Polyclonal origin of adjacent ventricular myocytes , 1992, Developmental dynamics : an official publication of the American Association of Anatomists.

[91]  Y Ikawa,et al.  Mice develop normally without tenascin. , 1992, Genes & development.

[92]  J. Sanger,et al.  Costameres are sites of force transmission to the substratum in adult rat cardiomyocytes , 1992, The Journal of cell biology.

[93]  E. Mackie,et al.  Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II. , 1992, The American journal of pathology.

[94]  J. Spring,et al.  Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues. , 1991, Cell regulation.

[95]  A. Cohen-Solal,et al.  [Ventricular "remodeling" after myocardial infarction]. , 1991, Archives des maladies du coeur et des vaisseaux.

[96]  I. Thesleff,et al.  Syndecan from embryonic tooth mesenchyme binds tenascin. , 1989, The Journal of biological chemistry.

[97]  M. Pfeffer,et al.  Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.

[98]  J. S. Janicki,et al.  Patterns of myocardial fibrosis. , 1989, Journal of molecular and cellular cardiology.

[99]  K. Weber,et al.  Cardiac interstitium in health and disease: the fibrillar collagen network. , 1989, Journal of the American College of Cardiology.

[100]  M. Chiquet,et al.  A major, six‐armed glycoprotein from embryonic cartilage. , 1987, The EMBO journal.

[101]  R. Chiquet‐Ehrismann,et al.  Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis , 1986, Cell.

[102]  M. Chiquet,et al.  Chick myotendinous antigen. II. A novel extracellular glycoprotein complex consisting of large disulfide-linked subunits , 1984, The Journal of cell biology.

[103]  J. Siliciano,et al.  Vinculin is a component of an extensive network of myofibril-sarcolemma attachment regions in cardiac muscle fibers , 1983, The Journal of cell biology.

[104]  C. S. Izzard,et al.  Formation of cell-to-substrate contacts during fibroblast motility: an interference-reflexion study. , 1980, Journal of cell science.